# FDA Inspection 1028938 - Similasan AG - September 18, 2017

Source: https://www.keypedia.com/records/fda_inspections/similasan-ag/e6c9f71b-4133-4e3e-9044-054d6c69fdcb
Source feed: FDA_Inspections

> FDA Inspection 1028938 for Similasan AG on September 18, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1028938
- Company Name: Similasan AG
- Inspection Date: 2017-09-18
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1204144 - 2023-04-04](https://www.keypedia.com/records/fda_inspections/similasan-ag/d03916c3-5fac-4fb3-a45e-302e5b3ce40f)
- [FDA Inspection 937801 - 2015-07-23](https://www.keypedia.com/records/fda_inspections/similasan-ag/0fe065aa-a821-461d-86b7-ad6277836807)
- [FDA Inspection 851899 - 2013-09-13](https://www.keypedia.com/records/fda_inspections/similasan-ag/0929ef3a-3aa6-4382-b1a9-e4b5f73587f7)
- [FDA Inspection 727380 - 2011-05-27](https://www.keypedia.com/records/fda_inspections/similasan-ag/231f3adb-8bff-4d3e-be18-9194e4827945)

Company: https://www.keypedia.com/companies/similasan-ag/c9b97bc2-9876-49bf-9b34-57cf8c5717e8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c